Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from HSIC

Henry Schein Stock Outlook: Is Wall Street Bullish or Bearish?

As a result of Henry Schein’s weak performance relative to the SPX over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution

Henry Schein Inc. (NASDAQ:HSIC) stock is trading lower on Tuesday after the company reported its second-quarter earnings.

Benzinga

Henry Schein's Quarterly Earnings Preview: What You Need to Know

Henry Schein is scheduled to report its second-quarter results next month, and analysts are projecting a single-digit decline in profits.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Henry Schein Stock Outperforming the Dow?

Henry Schein has outperformed the Dow over the past year, and analysts remain moderately optimistic about the stock’s prospects.

Barchart

Henry Schein's Q1 2025 Earnings: What to Expect

Henry Schein is gearing up to announce its Q1 results in the upcoming month, and analysts expect a modest increase in earnings.

Barchart

Is Henry Schein Stock Underperforming the Nasdaq?

Although Henry Schein has lagged behind the Nasdaq Composite, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s future.

Barchart

Is Wall Street Bullish or Bearish on Henry Schein Stock?

Henry Schein has trailed the broader market over the past year, yet analysts maintain a cautiously optimistic outlook on its future performance.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Henry Schein Earnings Preview: What to Expect

Henry Schein will announce its fourth-quarter earnings next month, and analysts are expecting a double-digit increase in earnings.

Barchart

Is Henry Schein Stock Underperforming the S&P 500?

Despite Henry Schein’s recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Henry Schein Stock?

Henry Schein has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

What You Need to Know Ahead of Henry Schein's Earnings Release

Henry Schein will release its third-quarter earnings next month, and analysts anticipate a double-digit profit dip.

Barchart

How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks?

Henry Schein outperformed its industry peers recently, and Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

What Are Wall Street Analysts' Target Price for Henry Schein Stock?

As Henry Schein underperformed the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

What to Expect From Henry Schein's Next Quarterly Earnings Report

With Henry Schein expected to release its Q2 earnings next month, analysts project a single-digit profit dip.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Henry Schein (HSIC) Q3 Earnings Analysis: A Medical Stock to Watch?

Henry Schein (HSIC) posted solid third-quarter 2023 sales growth and non-GAAP EPS growth despite continued lower sales of PPE products and COVID-19 test kits. In addition, the company’s long-term outlook appears bright, driven by sustained demand for its healthcare solutions and strategic investments. So, is it worth adding this medical…

StockNews.com

3 Dental Stocks That Will Keep You Smiling in 2022

The rebound in demand for dental care services and products with the easing of COVID-19 fears and adoption of advanced technologies in dental care bode well for the dental industry. Therefore, we think the stocks of quality dental companies Dentsply Sirona (XRAY), Patterson Companies (PDCO), and Henry Schein (HSIC) could…

Benzinga

Henry Schein's Return On Capital Employed Overview

Pulled from Benzinga Pro data, Henry Schein (NASDAQ:HSIC) posted Q1 earnings of $186.00 million, an increase from Q4 of 22.25%. Sales dropped to $3.18 billion, a 4.56% decrease between quarters.

Benzinga

Henry Schein Q1 Earnings Beat Street View, Sticks To FY22 Guidance

Henry Schein Inc (NASDAQ:HSIC) posts Q1 FY22 sales of $3.32 billion, beating the consensus of $3.13 billion, up 8.7% Y/Y, including 7.7% internal growth in local currencies, 2.4% growth from acquisitions, and a 1.4% decline related to foreign currency exchange. Q4 internal sales growth in local currencies, excluding personal protective equipment and COVID-19…

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

4 Medical Distributor Stocks That Deserve a Place in Your Portfolio

The rising demand for drugs and other medical products over the past few years has significantly increased the importance of healthcare distributors. Furthermore, the adoption of advanced and emerging technologies in the healthcare supply chain should help the medical distribution market grow robustly. So, we think the shares of fundamentally…

StockNews.com

3 Dental Stocks to Get Your Teeth Into

The dental care market is expected to grow in the coming years, propelled by an increasing geriatric population that is susceptible to dental disorders and people with unhealthy lifestyles that encourage chronic oral diseases. Furthermore, increasing government initiatives to strengthen oral healthcare infrastructure should help the industry grow. So, we…

Benzinga

Henry Schein Earnings Conference Call Is Coming Up, Here's What You Need To Know

Henry Schein (NASDAQ:HSIC) will host a conference call at 10:00 AM ET on May 3, 2022, to discuss Q1 2022 earnings results. How to Attend Henry Schein (HSIC) Conference Call Follow this link to access the live webcast.

StockNews.com

2 Medical Distribution Stocks Surging to New Highs with More Room to Run

The healthcare industry is expected to grow significantly, driven by the sustained demand from an aging population, advancements in medical technologies, and increased health awareness among individuals. Thus, we think it could be wise to invest in the fundamentally strong medical distribution stocks AmerisourceBergen (ABC) and Henry Schein (HSIC) with…

StockNews.com

5 Best Healthcare Stocks to Buy as a Hedge Against Inflation

The healthcare sector has historically provided a better hedge against inflation than gold because of the inelastic demand for its products and services. Rising healthcare needs of an aging population, integration of advanced technologies, and breakthroughs in clinical trials brighten the sector’s prospects. Therefore, fundamentally-sound and undervalued healthcare stocks Sanofi…

Benzinga

Henry Schein Q4 Topline, Bottom Line Beat Street View, FY22 Outlook Exceeds Consensus

Henry Schein Inc (NASDAQ: HSIC) posts

People

Mangeet Kaur BounsMangeet

595 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

AmerisourceBergen Corporation

14 stories

Medical – Devices & Equipment

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.